Katherine Stueland
Chief Executive Officer presso GENEDX HOLDINGS CORP.
Patrimonio netto: 543 589 $ in data 29/02/2024
Profilo
Presently, Katherine A.
Stueland occupies the position of President, Chief Executive Officer & Director at GeneDx Holdings Corp.
and President & Chief Executive Officer for GeneDx LLC (a subsidiary of GeneDx Holdings Corp.).
She is also on the board of Cancan Health.
In her past career she held the position of Chief Commercial Officer at Invitae Corp., Principal at Vivo Communications, LLC, President & Chief Executive Officer of GeneDx, Inc. and VP-Corporate Communications & Investor Relations at Dendreon Corp.
She received an undergraduate degree from Miami University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
18/03/2024 | 66 698 ( 0.26% ) | 543 589 $ | 29/02/2024 |
Posizioni attive di Katherine Stueland
Società | Posizione | Inizio |
---|---|---|
GENEDX HOLDINGS CORP. | Chief Executive Officer | 29/04/2022 |
Cancan Health | Director/Board Member | - |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The private company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Chief Executive Officer | 01/06/2021 |
Precedenti posizioni note di Katherine Stueland
Società | Posizione | Fine |
---|---|---|
INVITAE CORPORATION | Investor Relations Contact | 01/10/2016 |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Corporate Officer/Principal | 01/12/2013 |
DENDREON CORPORATION | Investor Relations Contact | 01/06/2012 |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Chief Executive Officer | - |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Director/Board Member | - |
Formazione di Katherine Stueland
Miami University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INVITAE CORPORATION | Health Services |
GENEDX HOLDINGS CORP. | Health Services |
Aziende private | 6 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Health Services |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Commercial Services |
Cancan Health | |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Communications |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The private company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Health Services |